Cannabinoid receptor modulators
US12109219B2 · kind B2 · utility
0Cited by
11References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 15, 2020 |
| Grant date | Oct 8, 2024 |
| Priority date | — |
| Expiry date | Oct 4, 2040 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided are certain methods useful in the treatment of cancer comprising administering a compound of Formula Ia and pharmaceutical compositions thereof that modulate the activity of the cannabinoid CB2 receptor;
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.